PATENT CLAIM ANALYSIS

Application Number: 15753188
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "001890"]

Abstract:
Subject matter of the present invention is PSMA Binding molecules for use in diagnosis and/or imaging of pain. Diagnosis or imaging of pain may be the visualization of the location of the origin of pain and/or the determination of the etiology of pain and/or the determination of the pain intensity and/or the stratification of subjects suffering from pain.

Claim (Index 17):
An in vitro method of imaging cells, organs, tissue samples, wherein the cells, organs or tissue samples are exposed to a chemical or physical stimulus suspect to be involved in the development or reduction of pain, and the expression and/or quantity of PSMA is determined using a PSMA-binding molecule as defined in  claim 1 .

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15639445', '14715115', '15764316', '14211683', '15385490']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7450232629575034
- 35 USC 102 Novelty (BERT): 0.524490770088022
- Combined Prediction Score: 0.7229700136705552
- Mean Citation Score: 279.99895000000004
- Max Citation Score: 326.13727
- Similarity Product: 222.8712579386365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test